X0306 4 2021-02-11 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001719325 Kenny John P. 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 1 Chief Executive Officer Common Stock 2021-02-11 4 M 0 1164 10.10 A 253340 D Common Stock 2021-02-11 4 S 0 1320 30.0011 D 252020 D Common Stock 2021-02-12 4 M 0 23097 10.10 A 275117 D Common Stock 2021-02-12 4 S 0 26181 30.1396 D 248936 D Stock Options (Right to Buy) 10.10 2021-02-11 4 M 0 1164 0 D 2029-11-05 Common Stock 1164 180821 D Stock Options (Right to Buy) 10.10 2021-02-12 4 M 0 23097 0 D 2029-11-05 Common Stock 23097 157724 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020. Prices range from $30.00 per share to $30.015 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020. Prices range from $30.00 per share to $30.49 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020. These non-qualified options were awarded under the 2012 Stock Incentive Plan pursuant to Mr. Kenny's Amended and Restated Employment Agreement effective October 1, 2019. The options vest on a pro rata basis over the three (3) years from the Agreement's effective date. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 15, 2020. /s/ Bryan T. Baldasare as Attorney-in-fact for John P. Kenny 2021-02-16